Co-author Network
sample of publications
-
articles
- 520 Systemic administration of PRELP reduces fibrotic traits in a genetic model of progressive fibrosis.. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 144:S318. 2024
- Epithelial-mesenchymal crosstalk communication promotes fibroblast activation and fibrosis in RDEB. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 143:S63-S63. 2023
- Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-beta antagonist and inhibitor of fibrosis. MATRIX BIOLOGY. 111:189-206. 2022
-
conference contributions